AmandaLeighOlsonMD

PubMed

• Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease.
  Curtis M Marcoux, Amin M Alousi, Jin Im, Laquisa C Hill, Portia Smallbone
  Bone Marrow Transplantation. 2024-11-01
• Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies.
  Supawee Saengboon, Stefan Ciurea, Uday Popat, Jeremy Ramdial, Qaiser Bashir
  Blood Advances. 2024-06-25
• SOHO State of the Art Updates and Next Questions | CTLs for Infections Following Stem Cell Transplantation.
  Ariel Rischall, Amanda Olson
  Clinical Lymphoma, Myeloma & Leukemia. 2024-06-01

Abstracts/Posters

• Post-Transplant Cyclophosphamide (PT-Cy) Based Haploidentical Cell Transplantation (Haplo) Versus Rabbit Anti-Thymocyte Globulin (r-ATG) Based HLA Matched Unrelated Do...
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Improved Outcomes for Patients Receiving High-Doses of IL-21 Ex Vivo Expanded NK Cells after Haploidentical Transplantation (haploSCT): Long-Term Follow-up of a Phase ...
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantat...
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Optimal Conditioning for Older Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Propensity Score Analysis
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
  Amanda L. Olson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation after Double Cord Blood Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018